82 related articles for article (PubMed ID: 19247294)
1. Biomarker debate highlights retrospective challenge.
Jones D
Nat Rev Drug Discov; 2009 Mar; 8(3):179-80. PubMed ID: 19247294
[No Abstract] [Full Text] [Related]
2. Colorectal cancer therapeutics and the challenges of applied pharmacogenomics.
Kruzelock RP; Short W
Curr Probl Cancer; 2007; 31(5):315-66. PubMed ID: 17905192
[No Abstract] [Full Text] [Related]
3. Personalized-medicine trials on the rise.
Benowitz S
J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
[No Abstract] [Full Text] [Related]
4. Colorectal cancer stem cells as biomarkers: where it all starts?
Avital I; Summers TA; Steele SR; Waldman S; Nissan A; Bilchik AJ; Protic M; Man YG; Brücher BL; Stojadinovic A
J Surg Oncol; 2013 Jun; 107(8):791-3. PubMed ID: 23512573
[No Abstract] [Full Text] [Related]
5. "Marking" of cancer: the road to clinical decision making.
Sudoyo AW
Acta Med Indones; 2010 Jan; 42(1):1. PubMed ID: 20737744
[No Abstract] [Full Text] [Related]
6. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
Chu E
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
[No Abstract] [Full Text] [Related]
7. Individualizing therapy for metastatic colorectal cancer.
Turja J; Grothey A
Oncology (Williston Park); 2008 Nov; 22(13):1479-81. PubMed ID: 19227569
[No Abstract] [Full Text] [Related]
8. Criticism of tumor response criteria raises trial design questions.
Twombly R
J Natl Cancer Inst; 2006 Feb; 98(4):232-4. PubMed ID: 16478740
[No Abstract] [Full Text] [Related]
9. [The pathologist and targeted therapies in oncology].
Bertheau P
Ann Pathol; 2009 Nov; 29 Spec No 1():S69-70. PubMed ID: 19887258
[No Abstract] [Full Text] [Related]
10. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
11. [Molecular markers having a prognostic or therapeutic value in cancer].
Brousset P
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
[No Abstract] [Full Text] [Related]
12. [Molecular biomarkers to predict outcome in colorectal cancer- current evidence and future perspectives].
Taniguchi H
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1367-71. PubMed ID: 25577804
[No Abstract] [Full Text] [Related]
13. Molecular markers of chemotherapy in advanced colorectal cancer: back to square one.
Sobrero A
Eur J Cancer; 2009 Jul; 45(11):1902-3. PubMed ID: 19502051
[No Abstract] [Full Text] [Related]
14. ASCO presentations highlight value of cancer biomarkers.
Opar A
Nat Rev Drug Discov; 2008 Jul; 7(7):547-8. PubMed ID: 18591972
[No Abstract] [Full Text] [Related]
15. Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.
Fine BM; Amler L
Clin Pharmacol Ther; 2009 May; 85(5):535-8. PubMed ID: 19295504
[No Abstract] [Full Text] [Related]
16. Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.
Berardi R; Maccaroni E; Onofri A; Giampieri R; Pistelli M; Bittoni A; Scartozzi M; Pierantoni C; Mandolesi A; Bearzi I; Cascinu S
Expert Opin Pharmacother; 2009 Oct; 10(15):2467-78. PubMed ID: 19761354
[TBL] [Abstract][Full Text] [Related]
17. Biomarker boom slowed by validation concerns.
Benowitz S
J Natl Cancer Inst; 2004 Sep; 96(18):1356-7. PubMed ID: 15367567
[No Abstract] [Full Text] [Related]
18. [Tailored treatment to patients with metastatic colorectal cancer].
Pfeiffer P; Qvortrup C; Hansen TP
Ugeskr Laeger; 2009 Mar; 171(13):1098. PubMed ID: 19321093
[No Abstract] [Full Text] [Related]
19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
Gindy ME; Prud'homme RK
Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
